Andrew Raubitschek
Institute of Neuroimmunology of the Slovak Academy of Sciences(SK)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Medical Imaging Techniques and Applications
Most-Cited Works
- → Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells(2008)716 cited
- → Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+B-Cell Non-Hodgkin's Lymphoma(1999)538 cited
- → CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results(2012)529 cited
- → In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses(2009)376 cited
- → Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T Cells(2004)366 cited
- Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.(1996)